Hear the wnt ror: How melanoma cells adjust to changes in Wnt

Pigment Cell and Melanoma Research

Volumn 22, Issue 6, 2009, Pages 724-739

  O'Connell, Michael P ^a   Weeraratna, Ashani T ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Clathrin; Endosome; Melanoma; Metastasis; Ror2; Wnt5A

Indexed keywords

BETA CATENIN; CYTOSKELETON PROTEIN; FRIZZLED PROTEIN; G PROTEIN COUPLED RECEPTOR; PROTEIN WNT 10A; PROTEIN WNT 10B; PROTEIN WNT 16; PROTEIN WNT 5B; PROTEIN WNT 6; PROTEIN WNT 7A; PROTEIN WNT 7B; PROTEIN WNT 8A; PROTEIN WNT 8B; PROTEIN WNT 9A; PROTEIN WNT 9B; PROTEOHEPARAN SULFATE; TUMOR ANTIGEN; UNCLASSIFIED DRUG; WNT PROTEIN; WNT1 PROTEIN; WNT11 PROTEIN; WNT3A PROTEIN; WNT5A PROTEIN;

ANTIGEN EXPRESSION; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL MATURATION; CELL MOTILITY; CELL SURFACE; CYTOSKELETON; HUMAN; INTERNALIZATION; MELANOCYTE; MELANOMA CELL; METASTASIS; NONHUMAN; PIGMENTATION; POSITIVE FEEDBACK; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN TARGETING; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TUMOR GROWTH;

BETA CATENIN; CELL DIFFERENTIATION; CYTOSKELETON; DISEASE PROGRESSION; FRIZZLED RECEPTORS; MELANOCYTES; MELANOMA; NEOPLASM METASTASIS; PIGMENTATION; PROTO-ONCOGENE PROTEINS; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; STEM CELLS; WNT PROTEINS;

EID: 70350100352     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2009.00627.x     Document Type: Review

References (160)

1. Ai, X., Do, A.T., Kusche-Gullberg, M., Lindahl, U., Lu, K. Emerson, C.P. Jr. (2006). Substrate specificity and domain functions of extracellular heparan sulfate 6-O-endosulfatases, QSulf1 and QSulf2. J. Biol. Chem. 281, 4969 4976.
2. Akbarzadeh, S., Wheldon, L.M., Sweet, S.M., Talma, S., Mardakheh, F.K. Heath, J.K. (2008). The deleted in brachydactyly B domain of ROR2 is required for receptor activation by recruitment of Src. PLoS ONE 3, e1873.
3. Arheden, K., Mandahl, N., Strombeck, B., Isaksson, M. Mitelman, F. (1988a). Chromosome localization of the human oncogene INT1 to 12q13 by in situ hybridization. Cytogenet. Cell Genet. 47, 86 87.
4. Arheden, K., Tommerup, N., Mandahl, N. et al. (1988b). Amplification of the human putative oncogene INT1 in primary retinoblastoma tumors. Cytogenet. Cell Genet. 48, 174 177.
5. Bachmann, I.M., Straume, O., Puntervoll, H.E., Kalvenes, M.B. Akslen, L.A. (2005). Importance of P-cadherin, β-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin. Cancer Res. 11, 8606 8614.
6. Badiglian Filho, L., Oshima, C.T., De Oliveira Lima, F., De Oliveira Costa, H., De Sousa Damiao, R., Gomes, T.S. Goncalves, W.J. (2009). Canonical and noncanonical Wnt pathway: a comparison among normal ovary, benign ovarian tumor and ovarian cancer. Oncol. Rep. 21, 313 320.
7. Baeg, G.H., Lin, X., Khare, N., Baumgartner, S. Perrimon, N. (2001). Heparan sulfate proteoglycans are critical for the organization of the extracellular distribution of Wingless. Development 128, 87 94.
8. Banziger, C., Soldini, D., Schutt, C., Zipperlen, P., Hausmann, G. Basler, K. (2006). Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. Cell 125, 509 522.
9. Bartscherer, K., Pelte, N., Ingelfinger, D. Boutros, M. (2006). Secretion of Wnt ligands requires Evi, a conserved transmembrane protein. Cell 125, 523 533.
10. Bellei, B., Flori, E., Izzo, E., Maresca, V. Picardo, M. (2008). GSK3beta inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes. Cell. Signal. 20, 1750 1761.
11. Benhaj, K., Akcali, K.C. Ozturk, M. (2006). Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol. Rep. 15, 701 707.
12. Billiard, J., Way, D.S., Seestaller-Wehr, L.M., Moran, R.A., Mangine, A. Bodine, P.V. (2005). The orphan receptor tyrosine kinase Ror2 modulates canonical Wnt signaling in osteoblastic cells. Mol. Endocrinol. 19, 90 101.
13. Bittner, M., Meltzer, P., Chen, Y. et al. (2000). Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536 540.
14. Blasband, A., Schryver, B. Papkoff, J. (1992). The biochemical properties and transforming potential of human Wnt-2 are similar to Wnt-1. Oncogene 7, 153 161.
15. Boyer, A., Paquet, M., Lague, M.N., Hermo, L. Boerboom, D. (2009). Dysregulation of WNT/CTNNB1 and PI3K/AKT signaling in testicular stromal cells causes granulosa cell tumor of the testis. Carcinogenesis 30, 869 878.
16. Cardones, A.R., Murakami, T. Hwang, S.T. (2003). CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin. Cancer Res. 63, 6751 6757.
17. Carroll, T.J., Wallingford, J.B. Vize, P.D. (1999). Dynamic patterns of gene expression in the developing pronephros of Xenopus laevis. Dev. Genet. 24, 199 207.
18. Casagrande, G., Te Kronnie, G. Basso, G. (2006). The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line. Haematologica 91, 765 771.
19. Chen, K., Fallen, S., Abaan, H.O. et al. (2008). Wnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival. Pediatr. Blood Cancer 51, 349 355.
20. Chien, A.J., Conrad, W.H. Moon, R.T. (2009a). A Wnt survival guide: from flies to human disease. J. Invest. Dermatol. 129, 1614 1627.
21. Chien, A.J., Moore, E.C., Lonsdorf, A.S. et al. (2009b). Activated Wnt/β-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc. Natl. Acad. Sci. USA 106, 1193 1198.
22. Da Forno, P.D., Pringle, J.H., Hutchinson, P., et al. (2008). WNT5A expression increases during melanoma progression and correlates with outcome. Clin Cancer Res. 14, 5825 5832.
23. Dejmek, J., Dib, K., Jonsson, M. Andersson, T. (2003). Wnt-5a and G-protein signaling are required for collagen-induced DDR1 receptor activation and normal mammary cell adhesion. Int. J. Cancer 103, 344 351.
24. Delehedde, M., Lyon, M., Sergeant, N., Rahmoune, H. Fernig, D.G. (2001). Proteoglycans: pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland. J. Mammary Gland Biol. Neoplasia 6, 253 273.
25. Delmas, V., Beermann, F., Martinozzi, S. et al. (2007). Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev. 21, 2923 2935.
26. Dennis, J.U., Dean, N.M., Bennett, C.F., Griffith, J.W., Lang, C.M. Welch, D.R. (1998). Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-alpha. Cancer Lett. 128, 65 70.
27. Dhoot, G.K., Gustafsson, M.K., Ai, X., Sun, W., Standiford, D.M. Emerson, C.P. Jr. 2001). Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science 293, 1663 1666.
28. Dissanayake, S.K., Wade, M., Johnson, C.E. et al. (2007). The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J. Biol. Chem. 282, 17259 17271.
29. Dissanayake, S.K., Olkhanud, P.B., O'Connell, M.P. et al. (2008). Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. Cancer Res. 68, 10205 10214.
30. Dong, J., Phelps, R.G., Qiao, R. et al. (2003). BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. Cancer Res. 63, 3883 3885.
31. Dorsky, R.I., Moon, R.T. Raible, D.W. (1998). Control of neural crest cell fate by the Wnt signalling pathway. Nature 396, 370 373.
32. Dunn, K.J., Williams, B.O., Li, Y. Pavan, W.J. (2000). Neural crest-directed gene transfer demonstrates Wnt1 role in melanocyte expansion and differentiation during mouse development. Proc. Natl. Acad. Sci. USA 97, 10050 10055.
33. Dunn, K.J., Brady, M., Ochsenbauer-Jambor, C., Snyder, S., Incao, A. Pavan, W.J. (2005). WNT1 and WNT3a promote expansion of melanocytes through distinct modes of action. Pigment Cell Res. 18, 167 180.
34. Endo, Y., Beauchamp, E., Woods, D., Taylor, W.G., Toretsky, J.A., Uren, A. Rubin, J.S. (2008). Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumor cells via a Frizzled3- and c-Jun N-terminal kinase-dependent mechanism. Mol. Cell. Biol. 28, 2368 2379.
35. Fang, D., Leishear, K., Nguyen, T.K. et al. (2006). Defining the conditions for the generation of melanocytes from human embryonic stem cells. Stem Cells 24, 1668 1677.
36. Filmus, J., Capurro, M. Rast, J. (2008). Glypicans. Genome Biol. 9, 224.
37. Ford, C.E., Ekstrom, E.J. Andersson, T. (2009a). Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells. Proc. Natl. Acad. Sci. USA 106, 3919 3924.
38. Ford, C.E., Ekstrom, E.J., Howlin, J. Andersson, T. (2009b). The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERalpha negative breast cancer. Cell Cycle 8, 1838 1842.
39. Fukukawa, C., Nagayama, S., Tsunoda, T., Toguchida, J., Nakamura, Y. Katagiri, T. (2009). Activation of the non-canonical Dvl-Rac1-JNK pathway by Frizzled homologue 10 in human synovial sarcoma. Oncogene 28, 1110 1120.
40. Ghosh, M.C., Collins, G.D., Vandanmagsar, B. et al. (2009). Activation of Wnt5A signaling is required for CXCL12-mediated T-cell migration. Blood 114, 1366 1373.
41. Golan, T., Yaniv, A., Bafico, A., Liu, G. Gazit, A. (2004). The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. β-catenin signaling cascade. J. Biol. Chem. 279, 14879 14888.
42. Goodman, R.M., Thombre, S., Firtina, Z. et al. (2006). Sprinter: a novel transmembrane protein required for Wg secretion and signaling. Development 133, 4901 4911.
43. Hamada, S., Watanabe, K., Hirota, M. et al. (2007). β-Catenin/TCF/ LEF regulate expression of the short form human Cripto-1. Biochem. Biophys. Res. Commun. 355, 240 244.
44. Heasley, L.E. Winn, R.A. (2008). Analysis of Wnt7a-stimulated JNK activity and cJun phosphorylation in non-small cell lung cancer cells. Methods Mol. Biol. 468, 187 196.
45. Herlyn, M., Berking, C., Li, G. Satyamoorthy, K. (2000). Lessons from melanocyte development for understanding the biological events in naevus and melanoma formation. Melanoma Res. 10, 303 312.
46. Hoek, K.S., Schlegel, N.C., Brafford, P. et al. (2006). Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 19, 290 302.
47. Hoek, K.S., Eichhoff, O.M., Schlegel, N.C. et al. (2008). In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 68, 650 656.
48. Howe, C.L., Valletta, J.S., Rusnak, A.S. Mobley, W.C. (2001). NGF signaling from clathrin-coated vesicles: evidence that signaling endosomes serve as a platform for the Ras-MAPK pathway. Neuron 32, 801 814.
49. Hsu, M.Y., Rovinsky, S., Penmatcha, S., Herlyn, M. Muirhead, D. (2005). Bone morphogenetic proteins in melanoma: angel or devil? Cancer Metastasis Rev. 24, 251 263.
50. James, R.G., Biechele, T.L., Conrad, W.H. et al. (2009). Bruton's tyrosine kinase revealed as a negative regulator of Wnt-β-catenin signaling. Sci. Signal. 2, ra25.
51. Jeays-Ward, K., Hoyle, C., Brennan, J., Dandonneau, M., Alldus, G., Capel, B. Swain, A. (2003). Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development 130, 3663 3670.
52. Jezewski, P.A., Fang, P.K., Payne-Ferreira, T.L. Yelick, P.C. (2008). Zebrafish Wnt9b synteny and expression during first and second arch, heart, and pectoral fin bud morphogenesis. Zebrafish 5, 169 177.
53. Jonsson, M. Andersson, T. (2001). Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells. J. Cell Sci. 114, 2043 2053.
54. Jonsson, M., Smith, K. Harris, A.L. (1998). Regulation of Wnt5a expression in human mammary cells by protein kinase C activity and the cytoskeleton. Br. J. Cancer 78, 430 438.
55. Jonsson, M., Dejmek, J., Bendahl, P.O. Andersson, T. (2002). Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res. 62, 409 416.
56. Juriloff, D.M., Harris, M.J., Mcmahon, A.P., Carroll, T.J. Lidral, A.C. (2006). Wnt9b is the mutated gene involved in multifactorial nonsyndromic cleft lip with or without cleft palate in A/WySn mice, as confirmed by a genetic complementation test. Birth Defects Res. A Clin. Mol. Teratol. 76, 574 579.
57. Kani, S., Oishi, I., Yamamoto, H. et al. (2004). The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. J. Biol. Chem. 279, 50102 50109. (Pubitemid 39577822)
58. Kashani-Sabet, M., Rangel, J., Torabian, S., et al. (2009). A multi-marker assay to distinguish malignant melanomas from benign nevi. Proc. Natl. Acad. Sci. U S A. 106, 6268 6272.
59. Katoh, M. (2005). WNT/PCP signaling pathway and human cancer (review). Oncol. Rep. 14, 1583 1588.
60. Katoh, M., Hirai, M., Sugimura, T. Terada, M. (1996). Cloning, expression and chromosomal localization of Wnt-13, a novel member of the Wnt gene family. Oncogene 13, 873 876.
61. Khan, N.I., Bradstock, K.F. Bendall, L.J. (2007). Activation of Wnt/β-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Br. J. Haematol. 138, 338 348.
62. Klein, D., Demory, A., Peyre, F. et al. (2009). Wnt2 acts as an angiogenic growth factor for non-sinusoidal endothelial cells and inhibits expression of stanniocalcin-1. Angiogenesis doi :.
63. Kremenevskaja, N., Von Wasielewski, R., Rao, A.S., Schofl, C., Andersson, T. Brabant, G. (2005). Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene 24, 2144 2154.
64. Kuhl, M., Sheldahl, L.C., Malbon, C.C. Moon, R.T. (2000a). Ca(2+)/calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus. J. Biol. Chem. 275, 12701 12711.
65. Kuhl, M., Sheldahl, L.C., Park, M., Miller, J.R. Moon, R.T. (2000b). The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet. 16, 279 283.
66. Kuphal, S., Palm, H.G., Poser, I. Bosserhoff, A.K. (2005). Snail-regulated genes in malignant melanoma. Melanoma Res. 15, 305 313.
67. Labonne, C. Bronner-Fraser, M. (1998). Neural crest induction in Xenopus: evidence for a two-signal model. Development 125, 2403 2414.
68. Lang, D., Lu, M.M., Huang, L. et al. (2005). Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 433, 884 887.
69. Larue, L. Delmas, V. (2006). The WNT/β-catenin pathway in melanoma. Front. Biosci. 11, 733 742.
70. Larue, L., Luciani, F., Kumasaka, M., Champeval, D., Demirkan, N., Bonaventure, J. Delmas, V. (2009) Bypassing melanocyte senescence by β-catenin: a novel way to promote melanoma. Pathol. Biol. (Paris) doi :.
71. Lavery, D.L., Martin, J., Turnbull, Y.D. Hoppler, S. (2008). Wnt6 signaling regulates heart muscle development during organogenesis. Dev. Biol. 323, 177 188.
72. Le Grand, F., Jones, A.E., Seale, V., Scime, A. Rudnicki, M.A. (2009). Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell Stem Cell 4, 535 547.
73. Legg, J.W., Lewis, C.A., Parsons, M., Ng, T. Isacke, C.M. (2002). A novel PKC-regulated mechanism controls CD44 ezrin association and directional cell motility. Nat. Cell Biol. 4, 399 407.
74. Li, Y. Bu, G. (2005). LRP5/6 in Wnt signaling and tumorigenesis. Future Oncol. 1, 673 681.
75. Li, C., Chen, H., Hu, L. et al. (2008). Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with FZD2. BMC Mol. Biol. 9, 11.
76. Lin, X. Perrimon, N. (2000). Role of heparan sulfate proteoglycans in cell-cell signaling in Drosophila. Matrix Biol. 19, 303 307. (Pubitemid 30665653)
77. Lin, Y.C., You, L., Xu, Z. et al. (2007). Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth. Hum. Gene Ther. 18, 379 386. (Pubitemid 46709349)
78. Liu, Y., Bhat, R.A., Seestaller-Wehr, L.M. et al. (2007). The orphan receptor tyrosine kinase Ror2 promotes osteoblast differentiation and enhances ex vivo bone formation. Mol. Endocrinol. 21, 376 387.
79. Lopes, C.C., Dietrich, C.P. Nader, H.B. (2006). Specific structural features of syndecans and heparan sulfate chains are needed for cell signaling. Braz. J. Med. Biol. Res. 39, 157 167.
80. Macleod, R.J., Hayes, M. Pacheco, I. (2007). Wnt5a secretion stimulated by the extracellular calcium-sensing receptor inhibits defective Wnt signaling in colon cancer cells. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G403 G411.
81. Mangioni, S., Vigano, P., Lattuada, D., Abbiati, A., Vignali, M. Di Blasio, A.M. (2005). Overexpression of the Wnt5b gene in leiomyoma cells: implications for a role of the Wnt signaling pathway in the uterine benign tumor. J. Clin. Endocrinol. Metab. 90, 5349 5355.
82. Mapelli, E., Banfi, P., Sala, E., Sensi, M., Supino, R., Zunino, F. Gambetta, R.A. (1994). Effect of protein kinase C inhibitors on invasiveness of human melanoma clones expressing different levels of protein kinase C isoenzymes. Int. J. Cancer 57, 281 286.
83. Martinez, G., Wijesinghe, M., Turner, K.N. et al. (2009). Conditional mutations of β-catenin and APC reveal roles for canonical Wnt signaling in lens differentiation. Invest. Ophthalmol. Vis. Sci. doi :.
84. Matsumoto, K., Miki, R., Nakayama, M., Tatsumi, N. Yokouchi, Y. (2008). Wnt9a secreted from the walls of hepatic sinusoids is essential for morphogenesis, proliferation, and glycogen accumulation of chick hepatic epithelium. Dev. Biol. 319, 234 247. In Press.
85. Mazieres, J., You, L., He, B. et al. (2005). Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis. Oncogene 24, 5396 5400.
86. Melchior, K., Weiss, J., Zaehres, H. et al. (2008). The WNT receptor FZD7 contributes to self-renewal signaling of human embryonic stem cells. Biol. Chem. 389, 897 903.
87. Mikels, A.J. Nusse, R. (2006). Purified Wnt5a protein activates or inhibits β-catenin-TCF signaling depending on receptor context. PLoS Biol. 4, e115.
88. Miyakoshi, T., Takei, M., Kajiya, H., Egashira, N., Takekoshi, S., Teramoto, A. Osamura, R.Y. (2008). Expression of Wnt4 in human pituitary adenomas regulates activation of the β-catenin-independent pathway. Endocr. Pathol. 19, 261 273.
89. Morioka, K., Tanikawa, C., Ochi, K. et al. (2009). Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma. Cancer Sci. 100, 1227 1233.
90. Morkel, M., Huelsken, J., Wakamiya, M. et al. (2003). β-Catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation. Development 130, 6283 6294.
91. Nakamura, T. Matsumoto, K. (2008). The functions and possible significance of Kremen as the gatekeeper of Wnt signalling in development and pathology. J. Cell Mol. Med. 12, 391 408.
92. Nakamura, K., Yoshikawa, N., Yamaguchi, Y., Kagota, S., Shinozuka, K. Kunitomo, M. (2003). Effect of PKC412, an inhibitor of protein kinase C, on spontaneous metastatic model mice. Anticancer Res. 23, 1395 1399.
93. Nawaz, S., Klar, J., Wajid, M. et al. (2009). WNT10A missense mutation associated with a complete Odonto-Onycho-Dermal Dysplasia syndrome. Eur. J. Hum. Genet. doi :.
94. Nemeth, M.J., Topol, L., Anderson, S.M., Yang, Y. Bodine, D.M. (2007). Wnt5a inhibits canonical Wnt signaling in hematopoietic stem cells and enhances repopulation. Proc. Natl. Acad. Sci. USA 104, 15436 15441.
95. Nishikawa, S. Osawa, M. (2007). Generating quiescent stem cells. Pigment Cell Res. 20, 263 270.
96. Nishita, M., Yoo, S.K., Nomachi, A. et al. (2006). Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration. J. Cell Biol. 175, 555 562.
97. Nomachi, A., Nishita, M., Inaba, D., Enomoto, M., Hamasaki, M. Minami, Y. (2008). Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein Filamin A. J. Biol. Chem. 283, 27973 27981.
98. Nyormoi, O. Bar-Eli, M. (2003). Transcriptional regulation of metastasis-related genes in human melanoma. Clin. Exp. Metastasis 20, 251 263. (Pubitemid 36513229)
99. O'Connell, M.P., French, A.D., Leotlela, P.D. Weeraratna, A.T. (2008). Assaying Wnt5A-mediated invasion in melanoma cells. Methods Mol. Biol. 468, 243 253.
100. O'Connell, M.P., Fiori, J.L., Baugher, K.M. et al. (2009a). Wnt5A activates the calpain-mediated cleavage of Filamin A. J. Invest. Dermatol. 129, 1782 1789.
101. O'Connell, M.P., Fiori, J.L., Kershner, E.K., et al. (2009b). HSPG modulation of WNT5A signal transduction in metastatic melanoma cells. J. Biol. Chem. doi :.
102. O'Connell, M.P., Fiori, J.L., Xu, M., et al. (2009c). The Orphan Tyrosine Kinase Receptor, ROR2, Mediates Wnt5A Signaling in Metastatic Melanoma. Oncogene doi :.
103. Oishi, I., Suzuki, H., Onishi, N. et al. (2003). The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 8, 645 654.
104. Okuyama, R., Tagami, H. Aiba, S. (2008). Notch signaling: its role in epidermal homeostasis and in the pathogenesis of skin diseases. J. Dermatol. Sci. 49, 187 194.
105. Ordway, J.M., Bedell, J.A., Citek, R.W. et al. (2006). Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets. Carcinogenesis 27, 2409 2423.
106. Park, J.K., Song, J.H., He, T.C., Nam, S.W., Lee, J.Y. Park, W.S. (2009). Overexpression of Wnt-2 in colorectal cancers. Neoplasma 56, 119 123.
107. Parri, M., Taddei, M.L., Bianchini, F., Calorini, L. Chiarugi, P. (2009). EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style. Cancer Res. 69, 2072 2081.
108. Pfeiffer, S., Ricardo, S., Manneville, J.B., Alexandre, C. Vincent, J.P. (2002). Producing cells retain and recycle Wingless in Drosophila embryos. Curr. Biol. 12, 957 962.
109. Pham, K., Milovanovic, T., Barr, R.J., Truong, T. Holcombe, R.F. (2003). Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features. Mol. Pathol. 56, 280 285.
110. Planutis, K., Planutiene, M., Moyer, M.P., Nguyen, A.V., Perez, C.A. Holcombe, R.F. (2007). Regulation of norrin receptor frizzled-4 by Wnt2 in colon-derived cells. BMC Cell Biol. 8, 12.
111. Pollock, P.M., Harper, U.L., Hansen, K.S. et al. (2003). High frequency of BRAF mutations in nevi. Nat. Genet. 33, 19 20.
112. Pons, M. Quintanilla, M. (2006). Molecular biology of malignant melanoma and other cutaneous tumors. Clin. Transl. Oncol. 8, 466 474.
113. Rajagopal, J., Carroll, T.J., Guseh, J.S. et al. (2008). Wnt7b stimulates embryonic lung growth by coordinately increasing the replication of epithelium and mesenchyme. Development 135, 1625 1634.
114. Rankin, J., Strachan, T., Lako, M. Lindsay, S. (1999). Partial cloning and assignment of WNT6 to human chromosome band 2q35 by in situ hybridization. Cytogenet. Cell Genet. 84, 50 52.
115. Rebhun, R.B., Lazar, A.J., Fidler, I.J. Gershenwald, J.E. (2008). Impact of sentinel lymphadenectomy on survival in a murine model of melanoma. Clin. Exp. Metastasis 25, 191 199.
116. Rhee, C.S., Sen, M., Lu, D. et al. (2002). Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 21, 6598 6605.
117. Riddle, R.D., Ensini, M., Nelson, C., Tsuchida, T., Jessell, T.M. Tabin, C. (1995). Induction of the LIM homeobox gene Lmx1 by WNT7a establishes dorsoventral pattern in the vertebrate limb. Cell 83, 631 640.
118. Rijsewijk, F., Schuermann, M., Wagenaar, E., Parren, P., Weigel, D. Nusse, R. (1987). The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 50, 649 657.
119. Rimm, D.L., Caca, K., Hu, G., Harrison, F.B. Fearon, E.R. (1999). Frequent nuclear/cytoplasmic localization of β-catenin without exon 3 mutations in malignant melanoma. Am. J. Pathol. 154, 325 329.
120. Robledo, M.M., Bartolome, R.A., Longo, N. et al. (2001). Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J. Biol. Chem. 276, 45098 45105.
121. Roelink, H., Wang, J., Black, D.M., Solomon, E. Nusse, R. (1993). Molecular cloning and chromosomal localization to 17q21 of the human WNT3 gene. Genomics 17, 790 792.
122. Rotolo, S., Diotti, R., Gordon, R.E. et al. (2005). Effects on proliferation and melanogenesis by inhibition of mutant BRAF and expression of wild-type INK4A in melanoma cells. Int. J. Cancer 115, 164 169.
123. Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E. Polakis, P. (1997). Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275, 1790 1792.
124. Safholm, A., Tuomela, J., Rosenkvist, J., Dejmek, J., Harkonen, P. Andersson, T. (2008). The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility. Clin. Cancer Res. 14, 6556 6563.
125. Saitoh, T. Katoh, M. (2001). Molecular cloning and characterization of human WNT5B on chromosome 12p13.3 region. Int. J. Oncol. 19, 347 351.
126. Saitoh, T. Katoh, M. (2002). Expression and regulation of WNT5A and WNT5B in human cancer: up-regulation of WNT5A by TNFalpha in MKN45 cells and up-regulation of WNT5B by β-estradiol in MCF-7 cells. Int. J. Mol. Med. 10, 345 349.
127. Saitoh, A., Hansen, L.A., Vogel, J.C. Udey, M.C. (1998). Characterization of Wnt gene expression in murine skin: possible involvement of epidermis-derived Wnt-4 in cutaneous epithelial-mesenchymal interactions. Exp. Cell Res. 243, 150 160.
128. Sakai, D., Tanaka, Y., Endo, Y., Osumi, N., Okamoto, H. Wakamatsu, Y. (2005). Regulation of Slug transcription in embryonic ectoderm by β-catenin-Lef/Tcf and BMP-Smad signaling. Dev. Growth Differ. 47, 471 482.
129. Saldanha, J., Singh, J. Mahadevan, D. (1998). Identification of a Frizzled-like cysteine rich domain in the extracellular region of developmental receptor tyrosine kinases. Protein Sci. 7, 1632 1635.
130. Schmidt, C., Mcgonnell, I., Allen, S. Patel, K. (2008). The role of Wnt signalling in the development of somites and neural crest. Adv. Anat. Embryol. Cell Biol. 195, 1 64.
131. Schulte, G. Bryja, V. (2007). The Frizzled family of unconventional G-protein-coupled receptors. Trends Pharmacol. Sci. 28, 518 525.
132. Schwartz, A.L., Malgor, R., Dickerson, E., et al. (2009). Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration. Clin. Cancer Res. 15, 4114 4122.
133. Sen, M., Chamorro, M., Reifert, J., Corr, M. Carson, D.A. (2001). Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation. Arthritis Rheum. 44, 772 781.
134. Shah, B.H., Shah, F.B. Catt, K.J. (2006). Role of metalloproteinase- dependent EGF receptor activation in alpha-adrenoceptor-stimulated MAP kinase phosphorylation in GT1-7 neurons. J. Neurochem. 96, 520 532.
135. Shibahara, S., Takeda, K., Yasumoto, K., Udono, T., Watanabe, K., Saito, H. Takahashi, K. (2001). Microphthalmia-associated transcription factor (MITF): multiplicity in structure, function, and regulation. J. Investig. Dermatol. Symp. Proc. 6, 99 104.
136. Swiatek, W., Tsai, I.C., Klimowski, L., Pepler, A., Barnette, J., Yost, H.J. Virshup, D.M. (2004). Regulation of casein kinase I epsilon activity by Wnt signaling. J. Biol. Chem. 279, 13011 13017.
137. Takahashi, Y., Nishikawa, M., Suehara, T., Takiguchi, N. Takakura, Y. (2008). Gene silencing of β-catenin in melanoma cells retards their growth but promotes the formation of pulmonary metastasis in mice. Int. J. Cancer 123, 2315 2320.
138. Takeda, K., Yasumoto, K., Takada, R. et al. (2000). Induction of melanocyte-specific microphthalmia-associated transcription factor by Wnt-3a. J. Biol. Chem. 275, 14013 14016.
139. Taki, M., Kamata, N., Yokoyama, K., Fujimoto, R., Tsutsumi, S. Nagayama, M. (2003). Down-regulation of Wnt-4 and up-regulation of Wnt-5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Cancer Sci. 94, 593 597.
140. Topol, L., Jiang, X., Choi, H., Garrett-Beal, L., Carolan, P.J. Yang, Y. (2003). Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent β-catenin degradation. J. Cell Biol. 162, 899 908.
141. Ulrich, F., Krieg, M., Schotz, E.M. et al. (2005). Wnt11 functions in gastrulation by controlling cell cohesion through Rab5c and E-cadherin. Dev. Cell 9, 555 564.
142. Ungar, A.R., Kelly, G.M. Moon, R.T. (1995). Wnt4 affects morphogenesis when misexpressed in the zebrafish embryo. Mech. Dev. 52, 153 164.
143. Voronkov, A.E., Baskin, I.I., Palyulin, V.A. Zefirov, N.S. (2008). Molecular model of the Wnt protein binding site on the surface of dimeric CRD domain of the hFZD8 receptor. Dokl. Biochem. Biophys. 419, 75 78.
144. Wai, D.H., Schaefer, K.L., Schramm, A. et al. (2002). Expression analysis of pediatric solid tumor cell lines using oligonucleotide microarrays. Int. J. Oncol. 20, 441 451.
145. Wainwright, B.J., Scambler, P.J., Stanier, P. et al. (1988). Isolation of a human gene with protein sequence similarity to human and murine int-1 and the Drosophila segment polarity mutant wingless. EMBO J. 7, 1743 1748.
146. Weeraratna, A.T. (2005). A Wnt-er wonderland-the complexity of Wnt signaling in melanoma. Cancer Metastasis Rev. 24, 237 250.
147. Weeraratna, A.T., Arnold, J.T., George, D.J., Demarzo, A. Isaacs, J.T. (2000). Rational basis for Trk inhibition therapy for prostate cancer. Prostate 45, 140 148.
148. Weeraratna, A.T., Becker, D., Carr, K.M., et al. (2004). Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome. Oncogene 23, 2264 2274.
149. Weeraratna, A.T., Dalrymple, S.L., Lamb, J.C., Denmeade, S.R., Miknyoczki, S., Dionne, C.A. Isaacs, J.T. (2001). Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells. Clin. Cancer Res. 7, 2237 2245.
150. Weeraratna, A.T., Jiang, Y., Hostetter, G., Rosenblatt, K., Duray, P., Bittner, M. Trent, J.M. (2002). Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1, 279 288.
151. Westfall, T.A., Brimeyer, R., Twedt, J., Gladon, J., Olberding, A., Furutani-Seiki, M. Slusarski, D.C. (2003). Wnt-5/pipetail functions in vertebrate axis formation as a negative regulator of Wnt/β-catenin activity. J. Cell Biol. 162, 889 898.
152. Wilson, C., Goberdhan, D.C. Steller, H. (1993). Dror, a potential neurotrophic receptor gene, encodes a Drosophila homolog of the vertebrate Ror family of Trk-related receptor tyrosine kinases. Proc. Natl. Acad. Sci. USA 90, 7109 7113.
153. Witze, E.S., Litman, E.S., Argast, G.M., Moon, R.T. Ahn, N.G. (2008). Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors. Science 320, 365 369.
154. Wolda, S.L. Moon, R.T. (1992). Cloning and developmental expression in Xenopus laevis of seven additional members of the Wnt family. Oncogene 7, 1941 1947.
155. Worm, J., Christensen, C., Gronbaek, K., Tulchinsky, E. Guldberg, P. (2004). Genetic and epigenetic alterations of the APC gene in malignant melanoma. Oncogene 23, 5215 5226.
156. Xiao, C., Yang, B.F., Song, J.H., Schulman, H., Li, L. Hao, C. (2005). Inhibition of CaMKII-mediated c-FLIP expression sensitizes malignant melanoma cells to TRAIL-induced apoptosis. Exp. Cell Res. 304, 244 255.
157. Yamaguchi, Y., Passeron, T., Hoashi, T. et al. (2008). Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/β-catenin signaling in keratinocytes. FASEB J. 22, 1009 1020.
158. Yokoyama, K., Kamata, N., Fujimoto, R. et al. (2003). Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. Int. J. Oncol. 22, 891 898.
159. You, L., He, B., Xu, Z. et al. (2004). An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. Cancer Res. 64, 5385 5389.
160. Zilberberg, A., Yaniv, A. Gazit, A. (2004). The low density lipoprotein receptor-1, LRP1, interacts with the human frizzled-1 (HFz1) and down-regulates the canonical Wnt signaling pathway. J. Biol. Chem. 279, 17535 17542.